Journal Of Gynecologic Oncology

SCI SCIE

国际简称：J GYNECOL ONCOL 参考译名：妇科肿瘤杂志

主要研究方向：ONCOLOGY-OBSTETRICS & GYNECOLOGY 非预警期刊审稿周期：>12周，或约稿

《妇科肿瘤杂志》(Journal Of Gynecologic Oncology)是一本由Korean Society of Gynecologic Oncology and Colposcopy出版的以ONCOLOGY-OBSTETRICS & GYNECOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
115 年发文量
4.2 IF影响因子
开放是否OA
30 H-index
2008 创刊年份
Quarterly 出版周期
English 出版语言

The Journal of Gynecologic Oncology (JGO) is an official publication of the Asian Society of Gynecologic Oncology. Abbreviated title is 'J Gynecol Oncol'. It was launched in 1990. The JGO's aim is to publish the highest quality manuscripts dedicated to the advancement of care of the patients with gynecologic cancer. It is an international peer-reviewed periodical journal that is published bimonthly (January, March, May, July, September, and November). Supplement numbers are at times published. The journal publishes editorials, original and review articles, correspondence, book review, etc.

[ 查看全部 ]

投稿咨询加急咨询

Journal Of Gynecologic Oncology期刊信息

ISSN：2005-0380
出版语言：English
是否OA：开放
E-ISSN：2005-0399
出版地区：SOUTH KOREA
是否预警：否
出版商：Korean Society of Gynecologic Oncology and Colposcopy
出版周期：Quarterly
创刊时间：2008
开源占比：0.9902
Gold OA文章占比：100.00%
OA被引用占比：0.5050...
出版国人文章占比：0.12
出版撤稿占比：0
研究类文章占比：92.17%

Journal Of Gynecologic Oncology CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

5.8

1.256

1.452

学科类别	分区	排名	百分位
大类：Medicine 小类：Obstetrics and Gynecology	Q1	29 / 218	86%
大类：Medicine 小类：Oncology	Q2	123 / 428	71%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Journal Of Gynecologic Oncology中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ONCOLOGY 肿瘤学 OBSTETRICS & GYNECOLOGY 妇产科学	3区 2区

Journal Of Gynecologic Oncology JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：OBSTETRICS & GYNECOLOGY	SCIE	Q1	15 / 143	89.9
学科：ONCOLOGY	SCIE	Q2	108 / 333	67.7
学科：OBSTETRICS & GYNECOLOGY	SCIE	Q1	18 / 143	87.76
学科：ONCOLOGY	SCIE	Q1	58 / 333	82.73

Journal Of Gynecologic Oncology历年数据统计

影响因子

中科院分区

Journal Of Gynecologic Oncology中国学者发文选摘

1、Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and prognostic biomarker in cervical cance
Author: Chen, Yinlong; Chen, Qin; Guo, Xiaoqing; Zheng, Qingliang

Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2026; Vol. 37, Issue 2, pp. -. DOI: 10.3802/jgo.2026.37.e20
2、Safety and efficacy of radical hysterectomy based on embryo development-originated in the treatment of early cervical cancer: a single-arm meta-analysi
Author: Wang, Yang; Lu, Qiao; Na, Jing; Wang, Xinyou; Li, Ya; Han, Shichao; Wang, Jun

Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2026; Vol. 37, Issue 1, pp. -. DOI: 10.3802/jgo.2026.37.e8
3、Genotype distribution and risk factors for human papillomavirus infectio
Author: Shen, Yanqing; Zhang, Zuwei; Shi, Shaole; Zhang, Caixia; Wang, Channi; Chen, Ye

Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2026; Vol. 37, Issue 1, pp. -. DOI: 10.3802/jgo.2026.37.e7
4、Risk factors associated with overall survival in patients with cervical cancer: a prospective cohort study in Western China comparing random survival forest and Cox proportional hazards model
Author: Mao, Zejia; Long, Ling; Yuan, Li; Xu, Qianjie; He, Misi; Lei, Haike; Zou, Dongling

Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2026; Vol. 37, Issue 1, pp. -. DOI: 10.3802/jgo.2026.37.e2
5、Constructing a prediction model for lymph node metastasis in patients with incidental finding of endometrial cancer based on Fully-Connected Networ
Author: Huang, Yuzhen; Lin, Qing; Liu, Wei; Ren, Yulan; Wang, Huaying; Xu, Zhiying; Xue, Yu; Zhou, Wanying; Liao, Jiongbo; Wang, Yiqin; Tan, Weimin; Yan, Bo; Chen, Xiaojun

Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2026; Vol. 37, Issue 1, pp. -. DOI: 10.3802/jgo.2026.37.e1
6、Bevacizumab combined with chemotherapy could be superior to chemotherapy alone in relapsed ovarian cancer after PARPi: evidence from a multi-center propensity score-matched analysi
Author: Zhong, Lin; Wang, Haixia; Lei, Cuirong; Zou, Dongling

Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e36
7、Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysi
Author: Zhang, Xinyue; Yang, Jie; Li, Sijian; Zhang, Tianyu; Yang, Jiaxin

Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e49
8、Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinom
Author: Yuan, Zhen; Zhou, Huimei; Cao, Dongyan; Yang, Jiaxin; Liu, Qian

Journal: JOURNAL OF GYNECOLOGIC ONCOLOGY. 2025; Vol. 36, Issue 3, pp. -. DOI: 10.3802/jgo.2025.36.e40